Your browser doesn't support javascript.
loading
Early Treatment of High-Risk Hospitalized Coronavirus Disease 2019 (COVID-19) Patients With a Combination of Interferon Beta-1b and Remdesivir: A Phase 2 Open-label Randomized Controlled Trial.
Tam, Anthony Raymond; Zhang, Ricky Ruiqi; Lung, Kwok-Cheung; Liu, Raymond; Leung, Ka-Yi; Liu, Danlei; Fan, Yujing; Lu, Lu; Lam, Athene Hoi-Ying; Chung, Tom Wai-Hin; Yip, Cyril Chik-Yan; Lo, Jenny; Wu, Alan Ka-Lun; Lee, Rodney; Sin, Simon; Ng, Pauline Yeung; Chan, Wai-Ming; Shum, Hoi-Ping; Yan, Wing-Wa; Chan, Jasper Fuk-Woo; Cheng, Vincent Chi-Chung; Lau, Chak-Sing; To, Kelvin Kai-Wang; Chan, Kwok-Hung; Yuen, Kwok-Yung; Hung, Ivan Fan-Ngai.
Affiliation
  • Tam AR; Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China.
  • Zhang RR; Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China.
  • Lung KC; State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, The University of Hong Kong, Hong Kong SAR, China.
  • Liu R; Department of Medicine, Pamela Youde Nethersole Eastern Hospital, Hong Kong SAR, China.
  • Leung KY; Department of Medicine and Geriatrics, Ruttonjee Hospital, Hong Kong SAR, China.
  • Liu D; State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, The University of Hong Kong, Hong Kong SAR, China.
  • Fan Y; Department of Microbiology, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China.
  • Lu L; Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China.
  • Lam AH; State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, The University of Hong Kong, Hong Kong SAR, China.
  • Chung TW; Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China.
  • Yip CC; State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, The University of Hong Kong, Hong Kong SAR, China.
  • Lo J; State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, The University of Hong Kong, Hong Kong SAR, China.
  • Wu AK; Department of Microbiology, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China.
  • Lee R; Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China.
  • Sin S; State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, The University of Hong Kong, Hong Kong SAR, China.
  • Ng PY; Department of Microbiology, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China.
  • Chan WM; Department of Microbiology, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China.
  • Shum HP; Department of Medicine and Geriatrics, Ruttonjee Hospital, Hong Kong SAR, China.
  • Yan WW; Department of Clinical Pathology, Pamela Youde Nethersole Eastern Hospital, Hong Kong SAR, China.
  • Chan JF; Department of Clinical Pathology, Pamela Youde Nethersole Eastern Hospital, Hong Kong SAR, China.
  • Cheng VC; Department of Intensive Care, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China.
  • Lau CS; Department of Intensive Care, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China.
  • To KK; Department of Intensive Care, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China.
  • Chan KH; Department of Intensive Care, Pamela Youde Nethersole Eastern Hospital, Hong Kong SAR, China.
  • Yuen KY; Department of Intensive Care, Pamela Youde Nethersole Eastern Hospital, Hong Kong SAR, China.
  • Hung IF; State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, The University of Hong Kong, Hong Kong SAR, China.
Clin Infect Dis ; 76(3): e216-e226, 2023 02 08.
Article in En | MEDLINE | ID: mdl-35762834

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Interferon beta-1b / COVID-19 / COVID-19 Drug Treatment Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Aged / Humans Language: En Journal: Clin Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2023 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Interferon beta-1b / COVID-19 / COVID-19 Drug Treatment Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Aged / Humans Language: En Journal: Clin Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2023 Type: Article Affiliation country: China